Check out TBRC’s sale today for
The hospital-acquired infections testing kits market consists of sales of hospital-acquired infections testing kits, devices and related services. Hospital acquired infections testing kits are used to check the infections associated with pathogens such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and clostridium difficile.
Global Hospital Acquired Infections Testing Kits Market Size And Drivers:
The global hospital acquired infection testing kit market is expected to grow from $0.90 billion in 2020 to $1.00 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The hospital-acquired infections testing kits market is expected to reach $1.49 billion in 2025 at a CAGR of 10.5%. The hospital-acquired infections (HAIs) are on the rise, affecting both the inpatients and outpatients.
Request For A Sample For The Global Hospital Acquired Infections Testing Kits Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
Trends In The Global Hospital Acquired Infections Testing Kits Market
The diagnostic tests involved in diagnosing HAIs such as flow cytometry, mass spectrometry, near-infrared spectroscopy, nucleic acid-based technologies are advancing in technologies, providing more accurate data. There has been a significant advancement in mass spectrometers, which quantifies known materials, and identifies unknown compounds within a sample. For instance, SCIEX’s X500 QTOF solves the challenge of contamination and is a compact device that does not compromise on resolution and accuracy. It gives results sooner and allows the operator to make data-driven decisions sooner.
Global Hospital Acquired Infections Testing Kits Market Segments:
The global hospital acquired infections testing market is further segmented –
By Product: Instrument & Reagents, Consumables
By Test Type: Pneumonia Infection, Urinary Tract Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA Infection, Others
By Application: Drug-Resistance Testing, Disease Testing
By Pathogen Type: Viral, Bacterial, Fungal
By Method of Treatment: Sterilization, Chemical, Radiation
By Geography: The global hospital acquired infections testing kits market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Hospital Acquired Infections Testing Kits Market At:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report
Hospital Acquired Infections Testing Kits Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides hospital acquired infections testing kits market overviews, analyzes and forecasts market size and growth for the global hospital acquired infections testing kits market, hospital acquired infections testing kits market share, hospital acquired infections testing kits market players, hospital acquired infections testing kits market segments and geographies, hospital acquired infections testing kits market’s leading competitors’ revenues, profiles and market shares. The hospital acquired infections testing kits market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
